DAX18.944 -1,3%ESt504.726 -1,4%MSCIW3.712 -0,3%Dow43.038 -0,8%Nas18.773 -0,1%Bitcoin87.234 +2,1%Euro1,0571 -0,3%Öl73,83 +0,9%Gold2.626 +0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Tesla A1CX3T Rheinmetall 703000 Super Micro Computer A40MRM Bayer BAY001 Palantir A2QA4J Siemens Energy ENER6Y EVOTEC 566480 MicroStrategy 722713 Amazon 906866 Volkswagen (VW) vz. 766403 thyssenkrupp 750000 Mercedes-Benz Group (ex Daimler) 710000 Coinbase A2QP7J RENK RENK73
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX tief im Minus -- Wall Street schwächer -- thyssenkrupp meldet erneut Milliardenverlust -- Rivian-CFO will sich von Millionen Rivian-Aktien trennen -- Super Micro, Xpeng im Fokus
Top News
EVOTEC-Aktie fällt: Möglicher Abwehrkampf trübt Übernahmefantasie EVOTEC-Aktie fällt: Möglicher Abwehrkampf trübt Übernahmefantasie
BofA streicht Empfehlung: Korrektur bei Siemens-Aktie geht weiter BofA streicht Empfehlung: Korrektur bei Siemens-Aktie geht weiter
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

BioNTech (ADRs) Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
99,40 EUR +4,40 EUR +4,63 %
XETRA
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.22,58 Mrd. EUR

KGV25,25Div. Rendite0,00%

WKNA2PSR2

ISINUS09075V1026

SymbolBNTX

BioNTech (ADRs) Aktien News

DatumMeistgelesen
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaThe Analyst Landscape: 17 Takes On BioNTech
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Wer­bungBioNTech (ADRs)-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
BenzingaBioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition
Financial TimesBioNTech strikes $950mn deal for Chinese drugmaker Biotheus
GlobeNewswireBioNTech to Acquire Biotheus to Boost Oncology Strategy
RSSSC 13G/A: An amendment to the SC 13G filing
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaBioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
BenzingaWhat Analysts Are Saying About BioNTech Stock
BenzingaBreaking Down BioNTech: 16 Analysts Share Their Views
MotleyFoolBioNTech Se (BNTX) Q3 2024 Earnings Call Transcript
BenzingaBioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3
GlobeNewswireBioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
GlobeNewswireBioNTech to Host Innovation Series R&D Day on November 14, 2024
ZacksBioNTech to Report Q3 Earnings: Is a Beat in the Cards?
GlobeNewswireBioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaForecasting The Future: 15 Analyst Projections For BioNTech
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
BenzingaGoogle DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
Financial TimesDeepMind and BioNTech build AI lab assistants for scientific research
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
GlobeNewswireBioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
RSS144: Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing

BioNTech (ADRs) News

BioNTech (ADRs) News: auf dieser Seite finden Sie alle BioNTech (ADRs) News und Nachrichten zur BioNTech (ADRs) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch BioNTech (ADRs) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um BioNTech (ADRs) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.